This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated NODAL Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-NODAL WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~39.6 kDa | |
| Gel | 15% (standard starting point) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Glycosylated + Cleaved | |
| Caveat | Processing-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 1 isoform(s) |
The M07627 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | SH-SY5Y cell lysate (catalog M07627) |
| Gel % | 15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Short semi-dry transfer; verify retention (standard starting point) |
| Membrane | 0.2 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | M07627; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
NODAL’s full-length precursor is predicted at 39.6 kDa; cleavage, N-linked sites, and disulfide-linked dimerization may affect bands, but migration has not been demonstrated here.
| Band near 39.6 kDa | consistent with the predicted full-length precursor; identity needs confirmation |
| Band below 39.6 kDa | could reflect signal peptide or propeptide cleavage |
| Band near twice the monomer position under non-reducing conditions | could reflect the disulfide-linked homodimer |
| Little or no band in whole-cell lysate | consistent with secretion of NODAL |
| Predicted full-length precursor mass | sets a 39.6 kDa reference, not a validated band position |
| N-linked glycosylation at Asn72 | may affect precursor migration; this site lies in the propeptide |
| N-linked glycosylation at Asn199 | may affect precursor migration; this site lies in the propeptide |
| Signal peptide and propeptide cleavage | can produce a mature chain smaller than the full-length precursor |
| Disulfide-linked homodimer | can yield a band near twice the monomer position under non-reducing or incompletely reducing conditions |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | NODAL is secreted | check conditioned medium alongside lysate |
| Band higher than expected | disulfide-linked dimers may persist with incomplete reduction | compare reducing and non-reducing lanes |
| Band lower than expected | signal peptide and propeptide cleavage can produce a smaller chain | compare precursor and mature-chain detection using an appropriate antibody |
| Multiple bands | precursor, processed chain, or disulfide-linked dimer may be present | compare reducing conditions and verify band identity with an independent antibody |
| Weak or no signal | secreted NODAL may be scarce in the sampled lysate | check conditioned medium and include a positive control |
| Fragments below expected size | propeptide cleavage creates a shorter mature chain | verify the antibody epitope and compare with a positive control |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for NODAL, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
The catalog reports one anti-NODAL antibody: M07627, a rabbit monoclonal with reported human reactivity. Its Western blot image shows Nodal expression in SH-SY5Y cell lysate; the supplied evidence does not establish performance in other samples.
Which to pick: M07627 is the only listed option and has a Western blot image using SH-SY5Y cell lysate. It is reported reactive with human samples; suitability for other contexts is not documented here.